Przybyszewski J, Malawski M, Licholai S
BMC Bioinformatics. 2023; 24(1):436.
PMID: 37978418
PMC: 10657114.
DOI: 10.1186/s12859-023-05564-x.
Yang Y, Lin Z, Han Z, Wu Z, Hua J, Zhong R
Cell Death Discov. 2021; 7(1):272.
PMID: 34601499
PMC: 8487425.
DOI: 10.1038/s41420-021-00659-x.
Nelson S, Roche S, Cotter M, Garcia P, Reitmeier D, Zollbrecht E
J Oncol. 2021; 2020:2951921.
PMID: 33424970
PMC: 7775161.
DOI: 10.1155/2020/2951921.
Liu Y, Zhang Y, Zheng Z, Li K, Wu X, Du Q
Oncol Lett. 2018; 15(5):6745-6751.
PMID: 29616134
PMC: 5876443.
DOI: 10.3892/ol.2018.8109.
Deng Z, Wang Y, Fang X, Yan F, Pan H, Gu L
Cancer Gene Ther. 2017; 24(7):282-288.
PMID: 28621315
DOI: 10.1038/cgt.2017.18.
Using miRNA-Analyzer for the Analysis of miRNA Data.
Guzzi P, Tradigo G, Veltri P
Microarrays (Basel). 2016; 5(4).
PMID: 27983673
PMC: 5197948.
DOI: 10.3390/microarrays5040029.
Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.
Yadav P, Mirza M, Nandi K, Jain S, Kaza R, Khurana N
Tumour Biol. 2016; 37(11):15275-15282.
PMID: 27696295
DOI: 10.1007/s13277-016-5361-y.
Radiation induces premature chromatid separation via the miR-142-3p/Bod1 pathway in carcinoma cells.
Pan D, Du Y, Ren Z, Chen Y, Li X, Wang J
Oncotarget. 2016; 7(37):60432-60445.
PMID: 27527863
PMC: 5312394.
DOI: 10.18632/oncotarget.11080.
MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2.
Tong Z, Jiang B, Wu Y, Liu Y, Li Y, Gao M
Int J Mol Sci. 2015; 16(7):14511-25.
PMID: 26132560
PMC: 4519855.
DOI: 10.3390/ijms160714511.
MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
Sun Y, Zhang T, Wang C, Jin X, Jia C, Yu S
PLoS One. 2015; 10(4):e0119783.
PMID: 25856297
PMC: 4391776.
DOI: 10.1371/journal.pone.0119783.
miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis.
Huang C, Sun C, Zhao F, Zhang Y, Li D
J Gastroenterol. 2014; 50(4):480-90.
PMID: 25155445
DOI: 10.1007/s00535-014-0986-3.
Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells.
Wu X, Ding N, Hu W, He J, Xu S, Pei H
Radiat Oncol. 2014; 9:179.
PMID: 25115181
PMC: 4252025.
DOI: 10.1186/1748-717X-9-179.
MicroRNA-21 is a novel promising target in cancer radiation therapy.
Liu J, Zhu H, Yang X, Ge Y, Zhang C, Qin Q
Tumour Biol. 2014; 35(5):3975-9.
PMID: 24446181
DOI: 10.1007/s13277-014-1623-8.
miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
Lu R, Ji Z, Li X, Zhai Q, Zhao C, Jiang Z
J Cancer Res Clin Oncol. 2014; 140(3):387-97.
PMID: 24384875
DOI: 10.1007/s00432-013-1577-z.
Pancreatic cancer diagnosis by free and exosomal miRNA.
Zoller M
World J Gastrointest Pathophysiol. 2013; 4(4):74-90.
PMID: 24340225
PMC: 3858795.
DOI: 10.4291/wjgp.v4.i4.74.
MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma.
Wang N, Zhang C, He J, Duan X, Wang Y, Ji X
Dig Dis Sci. 2013; 58(7):1863-70.
PMID: 23504349
DOI: 10.1007/s10620-013-2612-2.
MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients.
Doberstein K, Steinmeyer N, Hartmetz A, Eberhardt W, Mittelbronn M, Harter P
Neoplasia. 2013; 15(2):218-30.
PMID: 23441135
PMC: 3579323.
DOI: 10.1593/neo.121222.
MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines.
De Antonellis P, Liguori L, Falanga A, Carotenuto M, Ferrucci V, Andolfo I
Naunyn Schmiedebergs Arch Pharmacol. 2013; 386(4):287-302.
PMID: 23354452
DOI: 10.1007/s00210-013-0837-4.
MicroRNA-21 gene and cancer.
Huang Y, Yang Y, Zhang X, Yu X, Wang Z, Cheng X
Med Oncol. 2013; 30(1):376.
PMID: 23277281
DOI: 10.1007/s12032-012-0376-8.
Serum microRNA expression profile as a biomarker for the diagnosis of pertussis.
Ge Y, Zhao K, Qi Y, Min X, Shi Z, Qi X
Mol Biol Rep. 2012; 40(2):1325-32.
PMID: 23073777
DOI: 10.1007/s11033-012-2176-9.